News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,658 Results
Type
Article (2692)
Company Profile (26)
Press Release (82940)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (32917)
Career Advice (45)
Deals (5192)
Drug Delivery (1)
Drug Development (9893)
Employer Resources (2)
FDA (1457)
Job Trends (1941)
News (47562)
Policy (2687)
Tag
Academia (131)
Adcomms (1)
Allergies (8)
Alliances (3585)
ALS (12)
Alzheimer's disease (208)
Antibody-drug conjugate (ADC) (14)
Approvals (1514)
Artificial intelligence (25)
Autoimmune disease (4)
Automation (2)
Bankruptcy (10)
Best Places to Work (1935)
BIOSECURE Act (4)
Biosimilars (4)
Biotechnology (17)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (50)
Cancer (421)
Cardiovascular disease (54)
Career advice (38)
CAR-T (18)
Cell therapy (53)
Cervical cancer (7)
Clinical research (8799)
Collaboration (93)
Company closure (1)
Compensation (93)
Complete response letters (2)
COVID-19 (197)
CRISPR (4)
C-suite (36)
Cystic fibrosis (20)
Data (678)
Depression (10)
Diabetes (56)
Diagnostics (783)
Digital health (6)
Drug discovery (11)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (27060)
Editorial (1)
Employer resources (2)
Events (13765)
Executive appointments (64)
FDA (1882)
Frontotemporal dementia (2)
Funding (84)
Gene editing (8)
Generative AI (1)
Gene therapy (28)
GLP-1 (85)
Government (262)
Guidances (212)
Healthcare (2573)
HIV (5)
Huntington's disease (3)
IgA nephropathy (6)
Immunology and inflammation (12)
Immuno-oncology (1)
Indications (5)
Infectious disease (217)
Inflammatory bowel disease (12)
Influenza (12)
Intellectual property (14)
Interviews (4)
IPO (3951)
Job creations (133)
Job search strategy (36)
Kidney cancer (2)
Labor market (5)
Layoffs (22)
Leadership (1)
Legal (362)
Liver cancer (12)
Lung cancer (65)
Lymphoma (42)
Machine learning (2)
Manufacturing (38)
MASH (22)
Medical device (1741)
Medtech (1744)
Mergers & acquisitions (1348)
Metabolic disorders (139)
Multiple sclerosis (20)
NASH (1)
Neurodegenerative disease (15)
Neuropsychiatric disorders (5)
Neuroscience (305)
NextGen: Class of 2025 (517)
Non-profit (262)
Now hiring (1)
Obesity (51)
Opinion (3)
Ovarian cancer (10)
Pain (14)
Pancreatic cancer (25)
Parkinson's disease (25)
Partnered (2)
Patents (32)
Patient recruitment (19)
Peanut (4)
People (3783)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (2264)
Phase II (3845)
Phase III (3335)
Pipeline (884)
Policy (6)
Postmarket research (354)
Preclinical (774)
Press Release (14)
Prostate cancer (14)
Psychedelics (1)
Radiopharmaceuticals (29)
Rare diseases (57)
Real estate (356)
Recruiting (2)
Regulatory (2350)
Reports (20)
Research institute (130)
Resumes & cover letters (5)
Rett syndrome (3)
RSV (3)
Schizophrenia (12)
Series A (6)
Series B (6)
Service/supplier (3)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (29)
Sponsored (1)
Startups (199)
Stomach cancer (2)
Supply chain (3)
Tariffs (1)
The Weekly (1)
Vaccines (79)
Venture capital (1)
Weight loss (31)
Women's health (5)
Date
Today (11)
Last 7 days (43)
Last 30 days (283)
Last 365 days (5264)
2025 (3794)
2024 (6251)
2023 (7133)
2022 (10024)
2021 (9428)
2020 (8064)
2019 (5600)
2018 (4146)
2017 (3826)
2016 (2771)
2015 (3752)
2014 (2362)
2013 (1502)
2012 (1769)
2011 (1884)
2010 (1700)
Location
Africa (51)
Alabama (4)
Alaska (2)
Arizona (17)
Asia (5726)
Australia (599)
California (1351)
Canada (381)
China (122)
Colorado (65)
Connecticut (45)
Delaware (58)
Europe (11513)
Florida (229)
Georgia (56)
Idaho (4)
Illinois (70)
India (8)
Indiana (79)
Japan (27)
Kansas (79)
Kentucky (5)
Louisiana (6)
Maine (14)
Maryland (156)
Massachusetts (1071)
Michigan (29)
Minnesota (95)
Missouri (12)
Montana (4)
Nebraska (1)
Nevada (17)
New Hampshire (10)
New Jersey (507)
New York (589)
North Carolina (374)
Northern California (716)
Ohio (16)
Oregon (2)
Pennsylvania (284)
Rhode Island (4)
South America (98)
South Carolina (4)
Southern California (479)
Tennessee (10)
Texas (141)
United States (5446)
Utah (38)
Virginia (7)
Washington D.C. (5)
Washington State (136)
Wisconsin (10)
85,658 Results for "91".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 5, 2025
·
4 min read
Press Releases
Hera Biotech Acquires HeraFem, Advances Platform With 91% Sensitivity Point-of-care Cervical Cancer Diagnostic
June 17, 2025
·
3 min read
Press Releases
Pegfilgrastim Biosimilars Market to Reach USD 3.39 Billion by 2032, Expanding at a CAGR of 9.1% | Coherent Market Insights
June 10, 2025
·
1 min read
Press Releases
Fast Melt Tablets Market Size Reach USD 11.41 Billion by 2032, Growing at a CAGR of 9.1% from 2024 to 2032
June 10, 2025
·
1 min read
Press Releases
North America Molecular Diagnostics Market Size to Hit USD 8.91 Billion by 2034
February 26, 2025
·
1 min read
Alzheimer’s disease
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift” to first-generation FDA-approved antibodies.
July 28, 2025
·
2 min read
·
Dan Samorodnitsky
Isothermal Nucleic Acid Amplification Technology Market To Reach Over USD 8.91 Billion By The Year 2031
Global Isothermal Nucleic Acid Amplification Technology Market is valued at US$ 4.53 Bn in 2023, and it is expected to reach US$ 8.91 Bn by 2031, with a CAGR of 8.94% during the forecast period of 2024-2031.
April 29, 2024
·
5 min read
Press Releases
Genetic Testing Market Size Expected to Reach USD 91.30 Bn by 2034
December 2, 2024
·
1 min read
Press Releases
EGFR Inhibitors-Induced Skin Disorders Markets Expected to Grow at a CAGR Of 17.91% During 2025-2035, impelled by Advancements in Early Detection
January 30, 2025
·
7 min read
Press Releases
Iron Overload Syndrome Market Predicted to Grow at a Steady CAGR of 4.91% during 2025-2035, Impelled by Rising Prevalence of Iron-Related Disorders
February 3, 2025
·
8 min read
1 of 8,566
Next
